Literature DB >> 19339286

Graded response to thymectomy in children with myasthenia gravis.

Molly M Tracy1, Wes McRae, J Gordon Millichap.   

Abstract

Response to thymectomy in children with juvenile myasthenia gravis was evaluated using severity and response to therapy rating scales and objective measures of hospital, intensive care, and intubation days, prethymectomy and postthymectomy, as markers of morbidity. Records of 50 patients treated for myasthenia gravis at Children's Memorial Hospital, Chicago, were reviewed. Thymectomy was performed in 13 patients; average age was 10 years. Days of intubation, intensive care, and hospitalization were significantly less postthymectomy compared to prethymectomy (P < .0001). Osserman rankings postthymectomy were mild (IIa) in 1, moderate (IIb) in 4, and severe (III) in 1. On a response to therapy scale, 4 patients were grade A (complete remission, no medication); 3 were grade B (improvement, lower drug dosage); 3 were grade C (slight improvement and no change in medication); and 3 were grade D (unchanged). Thymectomy is an effective treatment in 62% of children with myasthenia gravis, and remission is complete in 31%.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339286     DOI: 10.1177/0883073808325653

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  11 in total

Review 1.  The role of thymectomy in the treatment of juvenile myasthenia gravis: a systematic review.

Authors:  Arin L Madenci; George Z Li; Brent R Weil; David Zurakowski; Peter B Kang; Christopher B Weldon
Journal:  Pediatr Surg Int       Date:  2017-04-11       Impact factor: 1.827

2.  Commentary on "Randomized trial of thymectomy in myasthenia gravis".

Authors:  Alexandar Tzankov
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

3.  Preliminary results of VATS thymectomy for pediatric myasthenia gravis.

Authors:  Ketan Parikh; Amrish Vaidya; Rajesh Jain
Journal:  Pediatr Surg Int       Date:  2011-06       Impact factor: 1.827

4.  Efficacy and safety of thoracoscopic thymectomy in the treatment of juvenile myasthenia gravis.

Authors:  Emily Christison-Lagay; Bela Dharia; Jiri Vajsar; Peter C Kim
Journal:  Pediatr Surg Int       Date:  2013-02-20       Impact factor: 1.827

5.  The effect of steroid treatment and thymectomy on bone age and height development in juvenile myasthenia gravis.

Authors:  Haiyan Wang; Zhe Su; Chuanming Luo; Yan Li; Huiyu Feng; Wei Fang; Chunyan Du; Juan Deng; Fei Yu; Weibin Liu
Journal:  Neurol Sci       Date:  2013-04-26       Impact factor: 3.307

6.  Anesthesia for patients undergoing transsternal thymectomy for juvenile myasthenia gravis.

Authors:  Lianne Stephenson; Igor Tkachenko; Robert Shamberger; Christian Seefelder
Journal:  Saudi J Anaesth       Date:  2011-01

7.  Juvenile myasthenia gravis: a paediatric perspective.

Authors:  Maria F Finnis; Sandeep Jayawant
Journal:  Autoimmune Dis       Date:  2011-11-01

8.  Autoimmune neuromuscular disorders in childhood.

Authors:  Hugh J McMillan; Basil T Darras; Peter B Kang
Journal:  Curr Treat Options Neurol       Date:  2011-12       Impact factor: 3.598

9.  Thymectomy in Juvenile Myasthenia Gravis Is Safe Regarding Long Term Immunological Effects.

Authors:  Trine H Popperud; Kiran A Gul; Cathrine Brunborg; Richard W Olaussen; Tore G Abrahamsen; Liv T Osnes; Emila Kerty
Journal:  Front Neurol       Date:  2021-02-25       Impact factor: 4.003

Review 10.  Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

Authors:  Nico Melzer; Tobias Ruck; Peter Fuhr; Ralf Gold; Reinhard Hohlfeld; Alexander Marx; Arthur Melms; Björn Tackenberg; Berthold Schalke; Christiane Schneider-Gold; Fritz Zimprich; Sven G Meuth; Heinz Wiendl
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.